COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 825: Articles 8241-8250  | Next

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
Lei, J., Clements, M., Elfström, M., Lundgren, K. C., Dillner, J.
10.1101/2022.04.22.22274163 — Posted: 2022-04-22
A within-host model of SARS-CoV-2 infection
Carruthers, J., Xu, J., Finnie, T. J. R., Hall, I.
10.1101/2022.04.22.22274137 — Posted: 2022-04-22
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
Orangi, S., Ojal, J., Brand, S. P. C., Orlendo, C., Kairu, A., Aziza, R., Ogero, M., Agweyu, A., Warimwe, G. M., Uyoga, S., Otieno, E., Ochola-Oyier, L. I., Agoti, C. N., Kasera, K., Amoth, P., Mwangangi, M., Aman, R., Ng'ang'a, W., Adetifa, I. M. O., Scott, J. A. G., Bejon, P., Keeling, M. J., Flasche, S., Nokes, D. J., Barasa, E.
10.1101/2022.04.21.22274150 — Posted: 2022-04-22
Prosocial motivation for vaccination
Reddinger, J. L., Charness, G., Levine, D.
10.1101/2022.04.21.22274110 — Posted: 2022-04-22
SARS-CoV-2 spike variants differ in their allosteric response to linoleic acid
Oliveira, A. S. F., Shoemark, D. F., Davidson, A. D., Berger, I., Schaffitzel, C., Mulholland, A. J.
10.1101/2022.04.21.489022 — Posted: 2022-04-22
The Free Fatty Acid-Binding Pocket is a Conserved Hallmark in Pathogenic β-Coronavirus Spike Proteins from SARS-CoV to Omicron
Toelzer, C., Gupta, K., Yadav, S. K. N., Hodgson, L., Kavanagh Williamson, M., Buzas, D., Borucu, U., Powers, K., Stenner, R., Vasileiou, K., Garzoni, F., Fitzgerald, D., Payre, C., Lambeau, G., Davidson, A. D., Verkade, P., Frank, M., Berger, I., Schaffitzel, C.
10.1101/2022.04.22.489083 — Posted: 2022-04-22
Intrinsic furin-mediated cleavability of the spike S1/S2 site from SARS-CoV-2 variant B.1.529 (Omicron)
Lubinski, B., Jaimes, J. A., Whittaker, G.
10.1101/2022.04.20.488969 — Posted: 2022-04-22
An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP Immunization
Hsu, F.-F., Liang, K.-H., Kumari, M., Chen, W. Y., Lin, H. T., Cheng, C. M., Tao, M.-H., Wu, H.-C.
10.1101/2022.04.20.488878 — Posted: 2022-04-22
Impaired immune response drives age-dependent severity of COVID-19
Beer, J., Crotta, S., Breithaupt, A., Ohnemus, A., Becker, J., Sachs, B., Kern, L., Llorian, M., Ebert, N., Labroussaa, F., Tran, T. T. N., Trueeb, B. S., Jores, J., Thiel, V., Beer, M., Fuchs, J., Kochs, G., Wack, A., Schwemmle, M., Schnepf, D.
10.1101/2022.04.21.489072 — Posted: 2022-04-22
A Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Dysregulation of the Neurovascular Unit Relevant to Brain Inflammation
Chiang, W., Litzburg, A., Yanchik-Slade, F., Li, H., Nilsson, B. L., Gelbard, H. A., Krauss, T. D.
10.1101/2022.04.20.488933 — Posted: 2022-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).